688189 南新制药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产176,584-4.49%184,895200,731223,585226,720
在建工程5933.49%5732401,275516
无形资产136,83910.10%124,284138,006158,41365,569
商誉10,8450.00%10,84510,84513,56928,256
其他非流动资产123,665-2.57%126,928108,614120,84651,814
448,5260.22%447,525458,436517,689372,875

流动资产
货币资金529,023-20.54%665,761713,472730,668299,351
应收账款503,751-7.39%543,962728,193590,813639,973
存货41,38545.64%28,41627,01561,42553,337
其他流动资产20,271-60.92%51,87227,492230,275720,483
1,094,430-15.16%1,290,0111,496,1721,613,1811,713,144

流动负债
短期借款155,121-51.97%322,950488,733385,437235,249
应付票据0--0080,0000
应付帐款33,193-16.07%39,54837,49676,46720,208
其他流动负债60,646-9.41%66,944122,127132,766126,141
248,959-42.03%429,442648,355674,671381,598
流动资产净值845,470-1.75%860,569847,817938,5101,331,546
资产总额减流动负债1,293,996-1.08%1,308,0951,306,2531,456,1991,704,421

非流动负债
长期借款0--0050,84676,260
应付债券0--0000
其他非流动负债5,301-8.10%5,7689,88111,3709,010
5,301-8.10%5,7689,88162,21685,270

总权益
    实收股本274,4000.00%274,400196,000140,000140,000
    储备项目1,031,271-1.19%1,043,7161,118,3651,253,1971,455,818
股东权益1,305,671-0.94%1,318,1161,314,3651,393,1971,595,818
非控股权益(16,977)7.52%(15,790)(17,993)78623,333